UPH Stock Overview
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 4/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
+ 1 more risk
U.S. Physical Therapy, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$95.50 |
52 Week High | US$111.00 |
52 Week Low | US$75.50 |
Beta | 1.38 |
1 Month Change | -5.45% |
3 Month Change | 9.77% |
1 Year Change | 0.53% |
3 Year Change | 0.53% |
5 Year Change | -5.39% |
Change since IPO | 636.88% |
Recent News & Updates
Recent updates
Shareholder Returns
UPH | DE Healthcare | DE Market | |
---|---|---|---|
7D | 4.4% | 2.7% | 0.5% |
1Y | 0.5% | -1.8% | 1.3% |
Return vs Industry: UPH matched the German Healthcare industry which returned 0.6% over the past year.
Return vs Market: UPH underperformed the German Market which returned 2.3% over the past year.
Price Volatility
UPH volatility | |
---|---|
UPH Average Weekly Movement | 4.1% |
Healthcare Industry Average Movement | 6.1% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: UPH has not had significant price volatility in the past 3 months.
Volatility Over Time: UPH's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1990 | 5,310 | Chris Reading | www.usph.com |
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
U.S. Physical Therapy, Inc. Fundamentals Summary
UPH fundamental statistics | |
---|---|
Market cap | €1.46b |
Earnings (TTM) | €16.91m |
Revenue (TTM) | €558.04m |
83.4x
P/E Ratio2.5x
P/S RatioIs UPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
UPH income statement (TTM) | |
---|---|
Revenue | US$598.63m |
Cost of Revenue | US$477.12m |
Gross Profit | US$121.51m |
Other Expenses | US$103.37m |
Earnings | US$18.14m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
Earnings per share (EPS) | 1.20 |
Gross Margin | 20.30% |
Net Profit Margin | 3.03% |
Debt/Equity Ratio | 22.5% |
How did UPH perform over the long term?
See historical performance and comparison